Marine Rushanyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, shared a post on LinkedIn:
“Presented my poster at ASCO26.
Our study examined reporting of sex-related data in landmark phase III solid tumor trial abstracts presented at ASCO 2025. Across practice-changing studies, sex-specific reporting was largely absent at the abstract level.
Grateful to my coauthors, mentors, and everyone who stopped by for the thoughtful discussions.”
Abstract: Reporting of sex-related data in landmark phase III solid tumor trials presented at ASCO 2025
Other articles featuring Marine Rushanyan on OncoDaily.
